NovoCure Limited
DE ˙ DB ˙ JE00BYSS4X48
13,66 € ↑0,85 (6,63%)
2026-06-04
DELAT PRIS
SecurityDE:038 / NovoCure Limited
InstitutionState Street Corp
Latest Disclosed Ownership2,561,817 shares
Latest Disclosed Value $ 27,923,805
State Street Corp reports 0.60% decrease in ownership of 038 / NovoCure Limited

On May 15, 2026 - State Street Corp filed a 13F-HR form disclosing ownership of 2,561,817 shares of NovoCure Limited (DE:038) valued at $22,569,608 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 2,577,239 shares of NovoCure Limited. This represents a change in shares of -0.60% during the quarter. The current value of the position is $35,007,229 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NOVOCURE ORD SHS G6674U108 2,561,817 -15,422 -0.60 27,924 -16.21 0.0010
2026-02-13 2025-12-31 13F NOVOCURE ORD SHS G6674U108 2,577,239 -33,449 -1.28 33,324 -1.21 0.0011
2025-11-14 2025-09-30 13F NOVOCURE ORD SHS G6674U108 2,610,688 -67,384 -2.52 33,730 -29.24 0.0012
2025-08-14 2025-06-30 13F NOVOCURE ORD SHS G6674U108 2,678,072 89,356 3.45 47,670 3.34 0.0018
2025-05-15 2025-03-31 13F NOVOCURE ORD SHS G6674U108 2,588,716 -52,729 -2.00 46,131 -41.40 0.0019
2025-02-14 2024-12-31 13F NOVOCURE ORD SHS G6674U108 2,641,445 -88,543 -3.24 78,715 84.48 0.0031
2024-11-14 2024-09-30 13F NOVOCURE ORD SHS G6674U108 2,729,988 -275,701 -9.17 42,670 -17.13 0.0017
2024-08-14 2024-06-30 13F NOVOCURE ORD SHS G6674U108 3,005,689 -357,176 -10.62 51,487 -2.04 0.0022
2024-05-15 2024-03-31 13F NOVOCURE ORD SHS G6674U108 3,362,865 -500,684 -12.96 52,562 -8.88 0.0023
2024-02-14 2023-12-31 13F NOVOCURE ORD SHS G6674U108 3,863,549 1,770,927 84.63 57,683 70.68 0.0028
2023-11-14 2023-09-30 13F NOVOCURE ORD SHS G6674U108 2,092,622 -374,012 -15.16 33,796 -66.99 0.0019
2023-08-14 2023-06-30 13F NOVOCURE ORD SHS G6674U108 2,466,634 -303,974 -10.97 102,365 -38.56 0.0054
2023-05-15 2023-03-31 13F NOVOCURE ORD SHS G6674U108 2,770,608 532,958 23.82 166,623 1.52 0.0094
2023-05-15 2022-12-31 13F/A-99 NOVOCURE ORD SHS G6674U108 2,237,650 -387,188 -14.75 164,132 -17.70 0.0096
2023-05-15 2022-12-31 13F NOVOCURE ORD SHS G6674U108 2,237,650 -387,188 164,132 0.0096
2022-11-15 2022-09-30 13F NOVOCURE ORD SHS G6674U108 2,624,838 336,243 14.69 199,435 25.39 0.0126
2022-08-15 2022-06-30 13F NOVOCURE ORD SHS G6674U108 2,288,595 -209,974 -8.40 159,057 -23.16 0.0095
2022-05-16 2022-03-31 13F NOVOCURE ORD SHS G6674U108 2,498,569 8,775 0.35 207,006 10.74 0.0102
2022-02-14 2021-12-31 13F NOVOCURE ORD SHS G6674U108 2,489,794 286,247 12.99 186,934 -26.97 0.0089
2021-11-15 2021-09-30 13F NOVOCURE ORD SHS G6674U108 2,203,547 -45,038 -2.00 255,986 -48.68 0.0135
2021-08-16 2021-06-30 13F NOVOCURE ORD SHS G6674U108 2,248,585 200,689 9.80 498,781 84.26 0.0263
2021-07-09 2021-03-31 13F/A-1 NOVOCURE ORD SHS G6674U108 2,047,896 113,215 5.85 270,691 -19.14 0.0155
2021-05-17 2021-03-31 13F NOVOCURE ORD SHS G6674U108 1,919,847 -14,834 253,765 0.0146
2021-02-16 2020-12-31 13F NOVOCURE ORD SHS G6674U108 1,934,681 782,901 67.97 334,777 161.13 0.0205
2020-11-10 2020-09-30 13F NOVOCURE ORD SHS G6674U108 1,151,780 64,557 5.94 128,205 98.85 0.0088
2020-08-14 2020-06-30 13F NOVOCURE ORD SHS G6674U108 1,087,223 -655,368 -37.61 64,472 -45.06 0.0047
2020-06-19 2020-03-31 13F/A-1 NOVOCURE ORD SHS G6674U108 1,742,591 73,981 4.43 117,346 -16.55 0.0103
2020-05-11 2020-03-31 13F NOVOCURE ORD SHS G6674U108 1,742,591 73,981 117,346 10,305.3416
2020-02-06 2019-12-31 13F NOVOCURE ORD SHS G6674U108 1,668,610 53,102 3.29 140,614 16.39 0.0096
2019-11-14 2019-09-30 13F NOVOCURE ORD SHS G6674U108 1,615,508 44,737 2.85 120,808 21.64 0.0090
2019-08-14 2019-06-30 13F NOVOCURE ORD SHS G6674U108 1,570,771 222,134 16.47 99,320 52.88 0.0074
2019-05-15 2019-03-31 13F NOVOCURE ORD SHS G6674U108 1,348,637 63,491 4.94 64,964 50.98 0.0051
2019-02-12 2018-12-31 13F NOVOCURE ORD SHS G6674U108 1,285,146 -61,238 -4.55 43,027 -39.01 0.0039
2018-11-09 2018-09-30 13F NOVOCURE Common equity shares G6674U108 1,346,384 24,657 1.87 70,549 70.54 0.0054
2018-08-14 2018-06-30 13F NOVOCURE Common equity shares G6674U108 1,321,727 211,513 19.05 41,369 70.94 0.0035
2018-05-15 2018-03-31 13F NOVOCURE Common equity shares G6674U108 1,110,214 -21,754 -1.92 24,201 5.85 0.0021
2018-02-14 2017-12-31 13F NOVOCURE Common equity shares G6674U108 1,131,968 52,740 4.89 22,864 6.72 0.0018
2017-11-14 2017-09-30 13F NOVOCURE Common equity shares G6674U108 1,079,228 -3,361 -0.31 21,425 14.40 0.0018
2017-08-14 2017-06-30 13F NOVOCURE Common equity shares G6674U108 1,082,589 157,642 17.04 18,728 149.91 0.0017
2017-05-15 2017-03-31 13F NOVOCURE Common equity shares G6674U108 924,947 64,818 7.54 7,494 11.02 0.0007
2017-02-09 2016-12-31 13F NOVOCURE Common equity shares G6674U108 860,129 -3,635 -0.42 6,750 -8.50 0.0006
2017-01-13 2016-09-30 13F/A-1 NOVOCURE Common equity shares G6674U108 863,764 82,593 10.57 7,377 -19.09 0.0007
2016-11-14 2016-09-30 13F NOVOCURE Common equity shares G6674U108 863,764 7,377
2016-08-12 2016-06-30 13F NOVOCURE Common equity shares G6674U108 781,171 658,632 537.49 9,117 414.21 0.0010
2016-05-20 2016-03-31 13F/A-1 NOVOCURE Common equity shares G6674U108 122,539 35,323 40.50 1,773 -9.03 0.0002
2016-05-12 2016-03-31 13F NOVOCURE Common equity shares G6674U108 122,539 1,773
2016-02-16 2015-12-31 13F NOVOCURE Common equity shares G6674U108 87,216 87,216 1,949 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.